RPID · Rapid Micro Biosystems, Inc.
$1.97
-0.02 (-1.01%)
At close · Jul 27
Market Cap
$91.88M
Shares
46.17M
Rapid Micro Biosystems, Inc. Earnings Call Transcripts
Every quarterly earnings call for Rapid Micro Biosystems, Inc. (RPID) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼31.3%
$4.74M
−$16.34M
'22 Q3
22-11-10
▼16%
$4.37M
−$16.45M
'22 Q4
23-03-03
▲21%
$5.04M
−$13.89M
'23 Q1
23-05-05
▲29.6%
$5.00M
−$14.02M
'23 Q2
23-08-04
▲29.7%
$6.14M
−$13.39M
'23 Q3
23-11-03
▲44.9%
$6.34M
−$11.17M
'23 Q4
24-03-01
▲11.4%
$5.61M
−$13.32M
'24 Q1
24-05-03
▲32.3%
$6.62M
−$12.58M
'24 Q2
24-08-02
▲23.7%
$7.60M
−$11.32M
'24 Q3
24-11-01
▲29.7%
$8.22M
−$9.67M
'24 Q4
25-02-28
▲28.4%
$7.21M
−$11.26M
'25 Q1
25-05-09
▲9.7%
$7.26M
−$11.86M
'25 Q2
25-08-12
▲3.1%
$7.84M
−$11.51M
'25 Q3
25-11-07
▲37.3%
$11.28M
−$12.50M
'25 Q4
26-03-12
LATEST
▲11.1%
$8.00M
−$14.28M
'26 Q1
26-05-13
Earnings call
FY26 · Q2
2026-08-07
Rapid Micro Biosystems Second Quarter 2026 Earnings Conference Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Rapid Micro Biosystems, Inc. Q1 FY2026 Earnings Call
Positive tone
Growth Direct system placements
Millipore Sigma collaboration
Gross margin expansion
Revenue
$8.00M
▲ 11.1% YoY Diluted EPS
$-0.31
Gross margin
4.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
Rapid Micro Biosystems, Inc. Q4 FY2025 Earnings Call
Confident tone
System placements & commercial wins
Gross margin expansion
Millipore Sigma collaboration
Revenue
$11.28M*
▲ 37.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-03-03
TD Cowen 46th Annual Health Care Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-07
Rapid Micro Biosystems, Inc. Q3 FY2025 Earnings Call
Confident tone
Multi-system record order
2026 growth drivers and outlook
Millipore Sigma partnership
Revenue
$7.84M
▲ 3.1% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Rapid Micro Biosystems, Inc. Q2 FY2025 Earnings Call
Positive tone
Q2 Revenue and Recurring Revenue
Gross Margin Expansion
U.S. Pharma Manufacturing / Onshoring
Revenue
$7.26M
▲ 9.7% YoY Diluted EPS
$-0.27
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-09
Rapid Micro Biosystems, Inc. Q1 FY2025 Earnings Call
Confident tone
Quarterly Revenue and Execution
Gross Margin Expansion
GrowthDirect System and Validations
Revenue
$7.21M
▲ 28.4% YoY Diluted EPS
$-0.26
Gross margin
5.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Rapid Micro Biosystems, Inc. Q4 FY2024 Earnings Call
Confident tone
MilliporeSigma distribution and collaboration agreement
Quarterly and full-year revenue performance
2025 guidance and conservatism on outlook
Revenue
$8.22M*
▲ 29.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-01
Rapid Micro Biosystems, Inc. Q3 FY2024 Earnings Call
Confident tone
Revenue growth and guidance
Gross margin improvement
System placements and land-and-expand
Revenue
$7.60M
▲ 23.7% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Rapid Micro Biosystems, Inc. Q2 FY2024 Earnings Call
Confident tone
2024 guidance and outlook
System placements and Growth Direct adoption
Operational efficiency and cash management
Revenue
$6.62M
▲ 32.3% YoY Diluted EPS
$-0.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Rapid Micro Biosystems, Inc. Q1 FY2024 Earnings Call
Confident tone
Growth Direct System Placements and Adoption
Recurring and Consumable Revenue
Gross Margin Improvement
Revenue
$5.61M
▲ 11.4% YoY Diluted EPS
$-0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-01
Rapid Micro Biosystems, Inc. Q4 FY2023 Earnings Call
Confident tone
Growth Direct system placements
Gross margin improvement
2024 guidance and financial outlook
Revenue
$6.34M*
▲ 44.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Rapid Micro Biosystems, Inc. Q3 FY2023 Earnings Call
Revenue
$6.14M
▲ 29.7% YoY Diluted EPS
$-0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Rapid Micro Biosystems, Inc. Q2 FY2023 Earnings Call
Revenue
$5.00M
▲ 29.6% YoY Diluted EPS
$-0.33
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Rapid Micro Biosystems, Inc. Q1 FY2023 Earnings Call
Revenue
$5.04M
▲ 21% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-03
Rapid Micro Biosystems, Inc. Q4 FY2022 Earnings Call
Revenue
$4.37M*
▼ 16% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Rapid Micro Biosystems, Inc. Q3 FY2022 Earnings Call
Revenue
$4.74M
▼ 31.3% YoY Diluted EPS
$-0.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
Rapid Micro Biosystems, Inc. Q2 FY2022 Earnings Call
Revenue
$3.86M
▼ 37% YoY Diluted EPS
$-0.31
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Rapid Micro Biosystems, Inc. Q1 FY2022 Earnings Call
Revenue
$4.16M
▼ 16.7% YoY Diluted EPS
$-0.35
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-04
Rapid Micro Biosystems, Inc. Q4 FY2021 Earnings Call
Revenue
$5.21M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Rapid Micro Biosystems, Inc. Q3 FY2021 Earnings Call
Revenue
$6.90M
▲ 31.5% YoY Diluted EPS
$-0.71
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-26
Rapid Micro Biosystems, Inc. Q2 FY2021 Earnings Call
Revenue
$6.13M
▲ 136.4% YoY Diluted EPS
$-20.01
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 earnings calls